Palvella Therapeutics: Mizuho cuts target price to $232 from $240
PVLA•Mizuho cut its target price for Palvella Therapeutics to $232 from $240.
Related News
LKQ publishes third-quarter 2026 earnings presentation
LKQ•
Stifel raises Teladoc Health target price to $6.5 from $5.5
TDOC•
Wedbush raises Etsy target price to $99 from $88
ETSY•
Cheniere Energy Q3 revenue $6,170 million vs. IBES estimate $5,360 million
LNG•
APi Group Q3 2026 net income rises 23% to $114 million
APG•